CB Insights Blog Roche targets two emerging battlegrounds — obesity and AI diagnostics — for its next growth phase

Roche — the world’s second-largest pharma company, with $65B in revenue in 2023 — is looking for new growth avenues amid a 7% drop in revenue YoY.  Using CB Insights data, we uncovered 4 strategic priorities highlighted by Roche’s acquisitions, … The post Roche targets two emerging battlegrounds — obesity and AI diagnostics — for its next growth phase appeared first on CB Insights Research.